Symbol
| ORAI1
| contributors: mct/npt/pgu - updated : 25-09-2015
|
HGNC name
| ORAI calcium release-activated calcium modulator 1
|
HGNC id
| 25896
|
corresponding disease(s)
|
IMD9
|
Other morbid association(s)
|
Type | Gene Modification | Chromosome rearrangement | Protein expression | Protein Function
|
---|
constitutional
|  
|  
|  
|  
|
a single missense mutation in ORAI1 in some SCID patients | |
Variant & Polymorphism
|
| |
Candidate gene
Marker
Therapy target
|
System | Type | Disorder | Pubmed |
cancer | reproductive | breast | |
Both ATP2C22 and ORAI1 emerge as druggable targets of therapeutic potential in the treatment of some breast cancer subtypes | neuromuscular | myopathy | | |
targeting Orai1 activity may be a promising therapeutic approach for the prevention and treatment of muscular dystrophy | allergy | asthm | | |
strategies that target ORAI1 or the BPIFA1 deficiency in asthma may lead to novel therapies to treat this disease |
| | | |